This study focuses on pressure ulcers (also known as bedsores or pressure sores) in patients admitted to the Intensive Care Unit (ICU). Pressure ulcers are localized injuries to the skin and/or underlying tissue, usually over a bony prominence, resulting from prolonged pressure on the skin. These injuries commonly occur in patients with limited mobility, such as those in intensive care. Pressure ulcers are classified into stages (I-IV) based on their severity, with stage I being the least severe
Conditions
Interventions
Intervention 1: Intervention group: Patients in this group receive all routine pressure ulcer care (similar to the control group) plus the following combination treatment:Hyalgen powder: Administered
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients admitted to the ICU for medical or surgical reasons. Patients diagnosed with stage one to four pressure ulcers (pressure injuries) through clinical assessment. Patients or their legally authorized representatives who provide informed consent. Patients aged 18 years and older.
Exclusion criteria
Exclusion criteria: Patients with known contraindications or allergies to bromelain or hylargen. Patients with severe coagulation disorders or active bleeding disorders. Patients with severe hepatic or renal failure Pregnant or breastfeeding women. Patients unable to provide informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in pressure ulcer size and severity. Timepoint: Baseline, 7 days, 14 days. Method of measurement: Method of measurement:Pain levels: Visual Analog Scale (VAS) and patient self-reportComplications: Clinical assessment and documentation of any wound-related complicationsQuality of life: Short Form-36 (SF-36) health survey questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNavid Shafigh
Shahid Beheshti University of Medical Sciences
Outcome results
None listed